HIV-2 (HUMAN IMMUNODEFICIENCY VIRUS TYPE 2) RNA QUANTITATIVE (VIRAL LOAD) BY RT-PCR, EDTA PLASMA

image not found

NABL Cap Accredited     
This test quantifies the amount of HIV-2 RNA in the blood using RT-PCR technology, providing a precise measurement of viral load. Monitoring HIV-2 viral load is essential for evaluating disease progression, treatment efficacy, and antiretroviral therapy management. Metropolis Healthcare uses highly sensitive molecular techniques to deliver accurate and reliable results from EDTA plasma. This test helps clinicians make informed decisions regarding patient care and therapy adjustments

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,240.00

Sample Type: EDTA PLASMA

Fasting Not Required


Notes: H0209

Frequently Asked Questions (FAQ's):

What does the HIV-2 viral load test measure?
It quantifies HIV-2 RNA in the blood to monitor infection severity and treatment response.

Who should undergo this test?
HIV-2 positive individuals, especially those on antiretroviral therapy, for monitoring and treatment guidance.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses RT-PCR, a highly sensitive molecular method, to accurately quantify HIV-2 RNA.

What type of sample is required?
An EDTA-anticoagulated plasma sample collected via routine venipuncture.

Is fasting required for this test?
No fasting or special preparation is necessary.

What does a high viral load indicate?
It suggests active viral replication and may indicate the need for treatment adjustment.

Can this test guide therapy decisions?
Yes, it helps clinicians monitor antiretroviral therapy efficacy and adjust treatment as needed.

How soon are results available from Metropolis Healthcare?
Results are generally available within 1–2 working days

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab